Alexander J Meeske

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Pseudomonas Aeruginosa

Circulating Tumor

Top Venues

Nature microbiology

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Mark A Katz, Edith M Sawyer, Luke Oriolt, Albina Kozlova, Madison C Williams, Shally R Margolis, Matthew Johnson, Joseph Bondy-Denomy, Alexander J Meeske
Diverse viral cas genes antagonize CRISPR immunity. Nature (2024)
Madison C Williams, Alexandra E Reker, Shally R Margolis, Jingqiu Liao, Martin Wiedmann, Enrique R Rojas, Alexander J Meeske
Restriction endonuclease cleavage of phage DNA enables resuscitation from Cas13-induced bacterial dormancy. Nature microbiology (2023)
Madison C Williams, Alexandra E Reker, Shally R Margolis, Jingqiu Liao, Martin Wiedmann, Enrique R Rojas, Alexander J Meeske
Restriction endonuclease cleavage of phage DNA enables resuscitation from Cas13-induced bacterial dormancy. Nature microbiology 8 (3) (2023)
Madison C Williams, Alexandra E Reker, Shally R Margolis, Jingqiu Liao, Martin Wiedmann, Enrique R Rojas, Alexander J Meeske
Restriction endonuclease cleavage of phage DNA enables resuscitation from Cas13-induced bacterial dormancy. Nature microbiology 8 (3) (2023)
Madison C Williams, Alexandra E Reker, Shally R Margolis, Jingqiu Liao, Martin Wiedmann, Enrique R Rojas, Alexander J Meeske
Restriction endonuclease cleavage of phage DNA enables resuscitation from Cas13-induced bacterial dormancy. Nature microbiology 8 (3) (2023)
Madison C Williams, Alexandra E Reker, Shally R Margolis, Jingqiu Liao, Martin Wiedmann, Enrique R Rojas, Alexander J Meeske
Restriction endonuclease cleavage of phage DNA enables resuscitation from Cas13-induced bacterial dormancy. Nature microbiology 8 (3) (2023)
Alexander J Meeske, Ning Jia, Alice K Cassel, Albina Kozlova, Jingqiu Liao, Martin Wiedmann, Dinshaw J Patel, Luciano A Marraffini
A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity. Science (New York, N.Y.) 369 (6499) (2020)